Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML
about
Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteinsSALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceCooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemiaThe RUNX genes: gain or loss of function in cancerAllele-specific KRT1 expression is a complex trait.RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutationsA murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Chromatin modification, leukaemia and implications for therapy.Dissecting the molecular mechanism of chronic myelogenous leukemia using murine models.Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice.The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.Animal models of acute myelogenous leukaemia - development, application and future perspectives.Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML.Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in miceReview: genetic models of acute myeloid leukaemia.The role of aberrant transcription factor in the progression of chronic myeloid leukemia.A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice.MYC and PIM2 co-expression in mouse bone marrow cells readily establishes permanent myeloid cell lines that can induce lethal myeloid sarcoma in vivoThe leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.RUNX1 translocations and fusion genes in malignant hemopathies.EVI1 induces myelodysplastic syndrome in mice.The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.Fadd and Skp2 are possible downstream targets of RUNX1-EVI1.Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia.
P2860
Q24291175-0F2CECDF-C4BB-4D5A-96A1-FF2FDC619D4EQ24685799-D735FAE8-1697-4C16-BFB0-E2AFD8E00D61Q28214984-CE9D3652-B11F-438C-A04A-D28B44134702Q28247901-9F47C6F6-337A-4227-BD00-033C2A769664Q33247455-22CD1C5C-D331-406E-BF49-8E37CC26D45EQ33759034-236D6381-57F4-45DE-B23B-7719BC09529CQ33943238-B3BD2E75-957B-4ABD-97E8-19918D03E3F4Q34064832-3D068504-A119-4E17-AEAF-14B0E6FD4177Q34786248-BB9D092B-84CB-4518-80A9-C1AECE4FE0F3Q34980358-709D0C7C-4824-4BF5-9035-A76F8D0242F9Q35009923-89C9F268-0D37-4E8F-AD3C-9AA88E171C81Q35022540-5C34FC6E-1463-4988-8EC1-00FCDFC45522Q36066980-C590411E-FD0C-4C3F-8CF0-5E94CC9D885EQ36233848-AADF259C-0FBB-4AFB-AFE8-D059C8FD73FAQ36239424-E589CDFC-3FCE-4992-A9E7-9224F32BF78AQ36379789-F77090DA-A28B-4159-850E-3799717E2A00Q36404458-901E866E-30BD-41E6-A6D7-8B705D89A2C3Q37080843-560F853A-F2D4-4D20-866C-AA7DDD1E0BE2Q37259355-FDC98A16-C711-43E3-89AD-3A7B0CFDCEECQ37431980-0E89E1A4-0D08-4722-94A1-A0C80DE83F84Q37461959-E6B3C7C7-3ACD-4DDA-876E-A0302F547F1FQ37513316-0A0902B6-7AB2-41BE-82FF-36CDD773AFB7Q37822736-6867EE36-0861-45E7-BB8D-2FDEADF4F1FAQ39951095-37FDE5BF-261C-489E-8E7B-A802A8ADAC8FQ40722488-62EFF081-6FE5-42C9-9552-9DE148B8AED7Q40736865-3458EA56-050F-48BB-A572-3BC57981407AQ42105764-94561A6B-7F9F-4858-977F-8904B5E4FAADQ42832388-17DC2703-7F6F-45C9-9BB9-D44363534233Q43213477-CE293519-5126-480C-9A1C-6437589083E0Q44175679-6E3BF723-FDBE-4427-A5D1-4F83E05DAF19Q45754556-EE7F37A5-2204-4ED6-847E-9981C55C9A33
P2860
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human AML1/MDS1/EVI1 fusion pr ...... in mice: a model for human AML
@en
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia
@nl
type
label
Human AML1/MDS1/EVI1 fusion pr ...... in mice: a model for human AML
@en
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia
@nl
prefLabel
Human AML1/MDS1/EVI1 fusion pr ...... in mice: a model for human AML
@en
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia
@nl
P2093
P2860
P356
P1476
Human AML1/MDS1/EVI1 fusion pr ...... in mice: a model for human AML
@en
P2093
P2860
P304
P356
10.1073/PNAS.030421197
P407
P577
2000-02-01T00:00:00Z